<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00937638</url>
  </required_header>
  <id_info>
    <org_study_id>PKE BOLD-X</org_study_id>
    <nct_id>NCT00937638</nct_id>
  </id_info>
  <brief_title>Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome</brief_title>
  <acronym>BOLD-X</acronym>
  <official_title>BOLD (Beef in an Optimal Lean Diet) Effects on Established and Emerging Cardiovascular Disease (CVD) Risk Factors: Effects on Metabolic Syndrome (BOLD-X)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cattlemen's Beef Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed research will provide important information about the role of 2 intervention
      diets that provide different amounts of lean beef and meet current nutrient recommendations
      for the treatment of Metabolic Syndrome (MetSyn), a chronic disease that is still increasing
      in prevalence at alarming rates. The experimental and diet designs will enable us to evaluate
      lifestyle interventions for MetSyn for persons who maintain weight, lose weight and maintain
      their weight loss, as is currently recommended in clinical practice. Importantly, the
      investigators will compare a diet high in lean beef (5 oz/day) which is compositionally
      similar (i.e., energy and nutrients) to the modified-DASH diet, a low beef diet which has
      become the Gold Standard for the management of cardiovascular disease (CVD) risk factors,
      including MetSyn. In addition, the investigators also will evaluate a moderate-high protein
      diet (BOLD+) that is higher in total protein (from mixed sources including lean beef,
      7oz/day) than the BOLD diet, on CVD risk factors in persons with MetSyn. A follow-up study
      was conducted to assess dietary compliance in a sub-sample of the population at 12-months;
      participants were not informed of this end-point and additional consent was obtained.

      Hypotheses:

        1. Healthful isocaloric diets that include lean beef as the primary source of protein (BOLD
           diet) with average (18%; BOLD) or moderate-high (28%; BOLD+) total protein intake will
           show similar or greater reductions in CVD risk, respectively when compared to a
           modified-DASH diet.

        2. A healthful weight-loss diet, including lean beef as the primary source of protein in a
           high-moderate protein diet (BOLD+ diet), plus regular exercise (BOLD+ + ex) will reduce
           body weight equal to that of a BOLD + ex and DASH + ex intervention, but may improve CV
           risk factors (such as BP and TG), and therefore reduce the prevalence of MetSyn more
           than a BOLD + ex and DASH + ex intervention.

        3. The BOLD diet will be more effective than the modified-DASH diet, and the BOLD+ diet
           more effective than the BOLD diet in maintaining the CVD benefits attained during phases
           1 and 2. Dietary adherence will be better on the BOLD and BOLD + diets compared with the
           modified DASH diet.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Criteria for Metabolic Syndrome: central obesity (weight, waist circumference, abdominal obesity), TG, HDL-C, glucose and BP</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Criteria for Metabolic Syndrome: central obesity (weight, waist circumference, abdominal obesity), TG, HDL-C, glucose and BP</measure>
    <time_frame>7 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Criteria for Metabolic Syndrome: central obesity (weight, waist circumference, abdominal obesity), TG, HDL-C, glucose and BP</measure>
    <time_frame>13 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Criteria for Metabolic Syndrome: central obesity (weight, waist circumference, abdominal obesity), TG, HDL-C, glucose and BP</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial function measured by endo-PAT</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipids and lipoproteins</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial function measured by endo-PAT</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial function measured by endo-PAT</measure>
    <time_frame>13 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial function measured by endo-PAT</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipids and lipoproteins</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipids and lipoproteins</measure>
    <time_frame>13 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipids and lipoproteins</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>13 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary analysis</measure>
    <time_frame>52 weeks</time_frame>
    <description>macro-and micronutrients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Criteria for Metabolic Syndrome: central obesity (weight, waist circumference) TG, HDL-C, glucose and BP</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Modified-DASH Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BOLD diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BOLD-X</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BOLD Diet</intervention_name>
    <description>Low-fat, high fruit and vegetable diet that includes lean beef (5oz/day)</description>
    <arm_group_label>BOLD diet</arm_group_label>
    <other_name>Low fat, Step II diet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BOLD-X Diet</intervention_name>
    <description>Low-fat, moderate-high protein diet (BOLD+) that is higher in total protein (from mixed sources including lean beef, 7oz/day) than the BOLD diet. Also high in fruits and vegetables</description>
    <arm_group_label>BOLD-X</arm_group_label>
    <other_name>Low fat, moderate protein</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Modified DASH Diet</intervention_name>
    <description>Low-fat, high fruit and vegetable diet which has become the Gold Standard for the management of cardiovascular disease (CVD) risk factors and metabolic syndrome</description>
    <arm_group_label>Modified-DASH Diet</arm_group_label>
    <other_name>DASH diet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (BMI 27-42 kg/m2)

          -  Three or more of the following risk factors (defined as having MetSyn):

               -  abdominal obesity [waist circumference &gt; 102 cm (40 inches) in men and &gt; 88 cm
                  (35 inches) in women],

               -  elevated blood glucose [&gt; 110mg/dl (6.1 mmol/L)]

               -  elevated TG [&gt;150 mg/dl (1.7 mmol/L)]

               -  low HDL-C [&lt;40 mg/dl (1.03 mmol/L) in men and &lt;50 mg/dL (1.29 mmol/l) in women]

               -  hypertension (Systolic Blood Pressure &gt; 130 mmHg or Diastolic Blood Pressure &gt; 85
                  mmHg)*

                    -  BP medication accepted if BP stable and less than 160/100mm Hg

        Exclusion Criteria:

          -  A history of myocardial infarction, stroke, diabetes mellitus, liver disease, kidney
             disease, and thyroid disease (unless controlled on medication)

          -  Lactation, pregnancy, or desire to become pregnant during the study

          -  Intake of putative cholesterol-lowering supplements (psyllium, fish oil capsules, soy
             lecithin, niacin, fiber, flax, and phytoestrogens, stanol/sterol supplemented foods)

          -  High alcohol consumption (â‰¥ 14 drinks/week)

          -  Participation in regular physical activity (&gt; 1 formal session/week)

          -  Lipid or glucose lowering medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Penny M Kris-Etherton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State University</name>
      <address>
        <city>University Park</city>
        <state>Pennsylvania</state>
        <zip>16802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2009</study_first_submitted>
  <study_first_submitted_qc>July 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <last_update_submitted>May 20, 2014</last_update_submitted>
  <last_update_submitted_qc>May 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penn State University</investigator_affiliation>
    <investigator_full_name>Penny Kris-Etherton</investigator_full_name>
    <investigator_title>Distinguished Professor of Nutrition</investigator_title>
  </responsible_party>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Lean Beef</keyword>
  <keyword>CVD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

